Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of daridorexant in participants with insomnia disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: Nxera Pharma Korea Co., Ltd. | Conditions: Insomnia Disorder | Phase 3 | Status: COMPLETED